BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/20/2013 9:38:37 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at American Society of Clinical Oncology
5/17/2013 9:15:56 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) to Present at the UBS Global Healthcare Conference
5/14/2013 9:06:32 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/18/2013 11:25:44 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Submits CTA for BMN-190 for Batten Disease
4/1/2013 10:26:25 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/19/2013 10:34:55 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Completes Partial Exchange of Convertible Notes Due 2017 for Common Stock
3/18/2013 12:41:48 PM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call and Webcast on Thursday, February 21 at 5:00 p.m. ET
1/31/2013 9:36:38 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1/18/2013 9:15:23 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Buys Zacharon Pharmaceuticals, Inc. for $10 Million
1/8/2013 8:15:36 AM
More...
|
|